메뉴 건너뛰기




Volumn 23, Issue 6, 2013, Pages 394-400

Are non-serious adverse reactions to psychiatric drugs really non-serious?

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATOMOXETINE; BENZODIAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; HALOPERIDOL; HYDROXYZINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PERICIAZINE; PHENOTHIAZINE DERIVATIVE; PROMAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID;

EID: 84882787944     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0094     Document Type: Article
Times cited : (11)

References (13)
  • 1
    • 84856197485 scopus 로고    scopus 로고
    • The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: A qualitative review of empirical studies
    • Aagaard L, Hansen EH: The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: A qualitative review of empirical studies. Neuropsychiatr Dis Treat 7:729-744, 2011
    • (2011) Neuropsychiatr Dis Treat , vol.7 , pp. 729-744
    • Aagaard, L.1    Hansen, E.H.2
  • 2
    • 84861076813 scopus 로고    scopus 로고
    • Adverse effects of second-generation antipsychotics in children and adolescents: A Bayesian meta-Analysis
    • Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C: Adverse effects of second-generation antipsychotics in children and adolescents: A Bayesian meta-Analysis. J Clin Psychopharmacol 32: 309-316, 2012
    • (2012) J Clin Psychopharmacol , vol.32 , pp. 309-316
    • Cohen, D.1    Bonnot, O.2    Bodeau, N.3    Consoli, A.4    Laurent, C.5
  • 3
    • 39349108186 scopus 로고    scopus 로고
    • Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: Epidemiology, prevention and management
    • Graham J, Coghill D: Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: Epidemiology, prevention and management. CNS Drugs 22:213-237, 2008
    • (2008) CNS Drugs , vol.22 , pp. 213-237
    • Graham, J.1    Coghill, D.2
  • 4
    • 84857167127 scopus 로고    scopus 로고
    • Antipsychotic medication prescribing trends in children and adolescents
    • Harrison JN, Cluxton-Keller F, Gross D: Antipsychotic medication prescribing trends in children and adolescents. J Pediatr Health Care 26:139-145, 2012
    • (2012) J Pediatr Health Care , vol.26 , pp. 139-145
    • Harrison, J.N.1    Cluxton-Keller, F.2    Gross, D.3
  • 5
    • 84871692604 scopus 로고    scopus 로고
    • Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: A review for primary care physicians
    • Hasnain MW, Victor RV, Hollett B: Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: A review for primary care physicians. PostgradMed 124:154-167, 2012
    • (2012) PostgradMed , vol.124 , pp. 154-167
    • Hasnain, M.W.1    Victor, R.V.2    Hollett, B.3
  • 7
    • 67649986279 scopus 로고    scopus 로고
    • Health-care costs of pediatric clients developing adverse events during treatment with antipsychotics
    • Jerrell JM, McIntyre RS: Health-care costs of pediatric clients developing adverse events during treatment with antipsychotics. Value Health 12:716-722, 2009
    • (2009) Value Health , vol.12 , pp. 716-722
    • Jerrell, J.M.1    McIntyre, R.S.2
  • 8
    • 84882808262 scopus 로고    scopus 로고
    • Therapeutic Drug monitoring for antidepressant drug treatment
    • Ostad Haji E, Hiemke C, Pfuhlmann B: Therapeutic Drug monitoring for antidepressant drug treatment. Curr Pharm Des 58:18-27, 2012
    • (2012) Curr Pharm des , vol.58 , pp. 18-27
    • Ostad Haji, E.1    Hiemke, C.2    Pfuhlmann, B.3
  • 9
    • 76049084742 scopus 로고    scopus 로고
    • Evidencebased use of second-generation antipsychotics in a state Medicaid pediatric population 20012005
    • Pathak P, West D, Martin BC, Helm ME, Henderson C: Evidencebased use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatr Serv 61:123-129, 2010
    • (2010) Psychiatr Serv , vol.61 , pp. 123-129
    • Pathak, P.1    West, D.2    Martin, B.C.3    Helm, M.E.4    Henderson, C.5
  • 11
    • 80051797913 scopus 로고
    • Risperidone in schizophrenia: Is there a role for therapeutic drug monitoring
    • Seto K, Dumontet J, Ensom MH: Risperidone in schizophrenia: Is there a role for therapeutic drug monitoring? Ther Drug Monit 33:275-83, 1995
    • (1995) Ther Drug Monit , vol.33 , pp. 275-783
    • Seto, K.1    Dumontet, J.2    Ensom, M.H.3
  • 12
    • 80054869842 scopus 로고    scopus 로고
    • What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association
    • Vilhelmsson A, Svensson T, Meeuwisse A, Carlsten A: What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association. BMC Clin Pharmacol 11:16, 2011
    • (2011) BMC Clin Pharmacol , vol.11 , pp. 16
    • Vilhelmsson, A.1    Svensson, T.2    Meeuwisse, A.3    Carlsten, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.